Press Releases

All Releases
10/31/2017
CRANBURY, N.J. , Oct. 31, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (Nasdaq: IPHS), today announced that its Board of Directors had declared a quarterly dividend of $0.48 per share of common stock. The dividend will be payable on December 6, 2017 to stockholders of record as of the close of
10/31/2017

Q3 Earnings Performance Exceeds Expectations<br>Novel Ingredients Integration Progressing as Planned<br>Full Year Revenue Guidance Raised; Earnings Guidance Maintained

10/18/2017
CRANBURY, N.J. , Oct. 18, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (Nasdaq: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients and custom-formulated solutions, today announced that the Company will host a conference call for investors and
09/19/2017
CRANBURY, N.J. , Sept. 19, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (Nasdaq: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients and custom-formulated solutions, today announced that the Company has been selected to receive the 2017 Corporate
08/28/2017
CRANBURY, N.J. , Aug. 28, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS) announced today that it has completed the acquisition of Novel Ingredients, previously announced on August 1, 2017 . The addition of Novel Ingredients advances Innophos' Vision 2022 strategy by growing Innophos'
08/02/2017
CRANBURY, N.J. , Aug. 2, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that Han Kieftenbeld , Senior Vice President and Chief Financial Officer, will address the Jefferies 2017 Industrials Conference , in New York City , on August 8, 2017 at 4:00 p.m.
08/01/2017
CRANBURY, N.J. , Aug. 1, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (Nasdaq: IPHS), today announced that its Board of Directors had declared a quarterly dividend of $0.48 per share of common stock. The dividend will be payable on September 6, 2017 to stockholders of record as of the close of
08/01/2017

Advances Vision 2022 Growth Strategy and Enhances Innovation<br>Expands Innophos' Offering in High-Growth Nutrition End-Markets<br>Company Anticipates Cost and Tax Synergies of Approximately $15 Million

08/01/2017

Q2 Revenue and Earnings Performance Exceeds Guidance<br>Positive Volume Trends and Operational Excellence Achievements Position Innophos to Deliver Robust Second Half 2017 In Line with Full Year Guidance<br>Innophos To Acquire Novel Ingredients To Create A Nearly $0.5 Billion Food, Health And Nutrition Platform Advancing Vision 2022 Growth Strategy

07/19/2017
CRANBURY, N.J. , July 19, 2017 /PRNewswire/ --  Innophos Holdings, Inc. (Nasdaq: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients and custom-formulated solutions, today announced that the Company will host a conference call for investors and